Health Care
Business & Economics
Putting Drug Research in Legal Jeopardy
The U.S. Supreme Court’s recent ruling in Wyeth v. Levine—holding that drug manufacturers are not free of liability under state law, even when the drug in question has secured federal regulatory approval—has worried pharmaceutical manufacturers, who can now face crippling state tort lawsuits despite being in regulatory compliance. A less-noticed ...
Business & Economics
For the Love of the Game
The 2009 Major League Baseball season starts on Sunday night, when the Atlanta Braves visit the Philadelphia Phillies. On Monday, 13 more clubs will host their Opening Day games. We asked a distinguished group of fans — one for each of MLB’s 30 teams — to account for their passion. ...
Commentary
Conservative Alliance Outlines 6 Deal-Killers for National Health Reform
Washington, April 1, 2009 –Medical costs are rising too fast, the quality of service is uneven and too many people have difficulty getting or keeping insurance coverage. Both left and right agree on the need to reform the American health care system. But not all agree on the best way ...
Commentary
Would the Health Reform Prescriptions Offered by President Obama and Congressional Leaders Help Patients?
Health Policy Consensus Group Statement By Thomas P. Miller, Scott Gottlieb, M.D., Robert B. Helms, Joseph Antos, Doug Badger, Robert A. Book, James C. Capretta, Greg D’Angelo, Stephen J. Entin, John C. Goodman, Linda Gorman, John R. Graham, Paul Guppy, John S. Hoff, Merrill Matthews, Amy Menefee, Robert E. Moffit, ...
Commentary
JAMA Wants to Restrict Competition for Pharma Dollars
Many elite, academic doctors would like to believe that they can create a world where human beings do not influence other human beings. This makes them ashamed of their profession’s relationship with research-based drug companies. They believe that any item or communication from a … more »»
Commentary
The “Congressional” Health Care Plan
With the highly publicized White House Forum on Health Reform now in the rearview mirror, President Obama has taken his show on the road. The administration is in the midst of holding five other such forums across the country. These gatherings are intended to set the stage for congressional action ...
Commentary
Leviathan’s Drug Problem: Federal Monopoly of Pharmaceutical Regulation and its Deadly Cost
A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration’s performance and concludes that the agency is overfunded, overstaffed, and denies hundreds of thousands of Americans timely access to new medicines. Leviathan’ s Drug Problem: The Cost of the Federal Monopoly ...
Commentary
FDA is Overfunded, Overstaffed, and Costs Lives According to New Pacific Research Institute Report
FDA is Overfunded, Overstaffed, and Costs Lives According to New Pacific Research Institute Report San Francisco (March 20, 2009) — A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration’s performance and concludes that the agency is overfunded, overstaffed, and denies ...
Commentary
The Myth of the 46 Million
“Even for folks who are weathering this economic storm, and have health care right now,” President Obama said at this month’s White House health care summit, “all it takes is one stroke of bad luck — an accident or an illness, a divorce, a lost job — to become one ...
Commentary
When America becomes Obamaland
There is one certainty about the shape of things to come if President Barack Obama wins approval of his extraordinarily ambitious proposals to remake America: We won’t recognize our country when he’s finished. Perhaps the most prominent feature of Obamaland will be long lines, starting with the unemployment offices, thanks ...
Putting Drug Research in Legal Jeopardy
The U.S. Supreme Court’s recent ruling in Wyeth v. Levine—holding that drug manufacturers are not free of liability under state law, even when the drug in question has secured federal regulatory approval—has worried pharmaceutical manufacturers, who can now face crippling state tort lawsuits despite being in regulatory compliance. A less-noticed ...
For the Love of the Game
The 2009 Major League Baseball season starts on Sunday night, when the Atlanta Braves visit the Philadelphia Phillies. On Monday, 13 more clubs will host their Opening Day games. We asked a distinguished group of fans — one for each of MLB’s 30 teams — to account for their passion. ...
Conservative Alliance Outlines 6 Deal-Killers for National Health Reform
Washington, April 1, 2009 –Medical costs are rising too fast, the quality of service is uneven and too many people have difficulty getting or keeping insurance coverage. Both left and right agree on the need to reform the American health care system. But not all agree on the best way ...
Would the Health Reform Prescriptions Offered by President Obama and Congressional Leaders Help Patients?
Health Policy Consensus Group Statement By Thomas P. Miller, Scott Gottlieb, M.D., Robert B. Helms, Joseph Antos, Doug Badger, Robert A. Book, James C. Capretta, Greg D’Angelo, Stephen J. Entin, John C. Goodman, Linda Gorman, John R. Graham, Paul Guppy, John S. Hoff, Merrill Matthews, Amy Menefee, Robert E. Moffit, ...
JAMA Wants to Restrict Competition for Pharma Dollars
Many elite, academic doctors would like to believe that they can create a world where human beings do not influence other human beings. This makes them ashamed of their profession’s relationship with research-based drug companies. They believe that any item or communication from a … more »»
The “Congressional” Health Care Plan
With the highly publicized White House Forum on Health Reform now in the rearview mirror, President Obama has taken his show on the road. The administration is in the midst of holding five other such forums across the country. These gatherings are intended to set the stage for congressional action ...
Leviathan’s Drug Problem: Federal Monopoly of Pharmaceutical Regulation and its Deadly Cost
A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration’s performance and concludes that the agency is overfunded, overstaffed, and denies hundreds of thousands of Americans timely access to new medicines. Leviathan’ s Drug Problem: The Cost of the Federal Monopoly ...
FDA is Overfunded, Overstaffed, and Costs Lives According to New Pacific Research Institute Report
FDA is Overfunded, Overstaffed, and Costs Lives According to New Pacific Research Institute Report San Francisco (March 20, 2009) — A new research report by the Pacific Research Institute (PRI) reviews three decades of the Food and Drug Administration’s performance and concludes that the agency is overfunded, overstaffed, and denies ...
The Myth of the 46 Million
“Even for folks who are weathering this economic storm, and have health care right now,” President Obama said at this month’s White House health care summit, “all it takes is one stroke of bad luck — an accident or an illness, a divorce, a lost job — to become one ...
When America becomes Obamaland
There is one certainty about the shape of things to come if President Barack Obama wins approval of his extraordinarily ambitious proposals to remake America: We won’t recognize our country when he’s finished. Perhaps the most prominent feature of Obamaland will be long lines, starting with the unemployment offices, thanks ...
